About Biomodex
Biomodex is a Healthcare company based in Paris (France) founded in 2014, and was acquired by Mentice in January 2023. 3D printed surgical simulators for medical education and patient-specific preoperative planning. It operates in the Healthcare and Technology sectors. Biomodex has raised $18.6 million across 2 funding rounds from investors including Idinvest Partners, Mentice and Innovation Capital. Biomodex offers products and services including Biorealistic Haptic Simulators and 3D Printed Models. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its legal entity is BIOMODEX CORPORATION. Its competitors include eCential Robotics, inHEART and SurgAR; 3 of its 3 listed competitors have raised funding.
Company details
Biomodex develops 3D printed surgical simulators for medical education and patient-specific preoperative planning. The company uses techniques three-dimensional modeling and advanced 3D printers to produce exact copies of organs that can be used to train staff medical and under preoperative simulations. From biomedical imaging data of organs from MRI or scanners, the company has developed a process that helps to automate the creation of virtual 3D models of these organs which can then be printed using a 3D printer. Products are offered for bone drilling, soft tissue suturing, and medical device implantation and sizing, including pathology specifications, medical imaging segmentation, biomechanical modeling, organ 3D printing, simulation environment, and surgical simulation procedures. The company received an investment of 3.6M led by Innovation Capital to expand in the US.
- Headquarters Paris, France
- Stage Acquired
- SectorsHealthcareTechnology
- Website biomodex.com
- Social LinkedIn X Facebook
- Acquired by Mentice (Jan 2023)
- Legal Name Biomodex Corporation
- Total Equity Funding$18.6M (USD)
in 2 rounds
- Latest Funding Round$15M (USD), Series A
May 2018
- InvestorsIdinvest Partners
& 5 more
- Acquired byMentice
(Jan 2023)
Products & Services of Biomodex
Biomodex offers a comprehensive portfolio of products and services, including Biorealistic Haptic Simulators and 3D Printed Models.
Enables realistic medical training with 3D models for procedure rehearsals
Facilitates patient-specific practice for advanced physician education quickly
Funding Insights of Biomodex
Biomodex has successfully raised a total of $18.6M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $15 million completed in May 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $18.6M
- Total Rounds 2
- Last Round Series A — $15M
- First Round $3.6M
(Apr 2016)
- Investors Count 5
All 2 funding rounds of Biomodex with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2018 | $15M | Series A | – | Idinvest Partners | |
| Apr 2016 | $3.6M | Series A | – | Innovation Capital |
6 investors in total: 6 institutional.
Investors in Biomodex
Biomodex has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Idinvest Partners, Mentice and Innovation Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Equity investments are provided to low and middle market companies. | 1997 | idinvest.com | Paris, France | |
Private equity investments are made in France and the US. | lbofrance.com | Paris, France | ||
| inserm-transfert-initiative.com | ||||
| allianz.fr | ||||
A blog on innovation and growth capital is provided. | 1996 | innovationcapital.fr | Paris, France | |
Simulation solutions for cardiovascular and neurovascular physician training are provided. | 1999 | mentice.com | Gothenburg, Sweden |
Investor details for Biomodex
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Biomodex
4 dated milestones of Biomodex across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Biomodex is founded.
- Funding First funding round of $3.6M.
- Funding Latest funding round, Series A, of $15.0M.
- Exit Acquired by Mentice.
Competitors of Biomodex
Biomodex has 3 listed competitors in our database, 3 of them funded. They include eCential Robotics, inHEART and SurgAR.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ecential-robotics.com | 2009 | Gieres, France | $133.97M | Robotic surgery platform for bone procedures is developed. | ||
| inheartmedical.com | 2017 | Pessac, France | $15.16M | AI-based 3D cardiac models are developed for therapeutic planning. | ||
| surgar-surgery.com | 2019 | Clermont Ferrand, France | $14.39M | Augmented reality software is developed for laparoscopic surgery applications. |
Detailed competitors of Biomodex
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biomodex
Complete news archive for Biomodex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biomodex
Biomodex was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Biomodex is headquartered in Paris, France.
Biomodex is a funded company, having raised a total of $18.6M across 2 funding rounds to date. The company's 1st funding round was a Series A of $3.6M, raised on Apr 2016.
Biomodex develops 3D printed surgical simulators for medical education and patient-specific preoperative planning. The company uses techniques three-dimensional modeling and advanced 3D printers to produce exact copies of organs that can be used to train staff medical and under preoperative simulations. From biomedical imaging data of organs from MRI or scanners, the company has developed a process that helps to automate the creation of virtual 3D models of these organs which can then be printed using a 3D printer. Products are offered for bone drilling, soft tissue suturing, and medical device implantation and sizing, including pathology specifications, medical imaging segmentation, biomechanical modeling, organ 3D printing, simulation environment, and surgical simulation procedures. The company received an investment of 3.6M led by Innovation Capital to expand in the US.
Biomodex's top competitors include eCential Robotics, SurgAR and inHEART.
Biomodex offers Biorealistic Haptic Simulators and 3D Printed Models.
Biomodex has 6 investors. Key investors include Idinvest Partners, Mentice, Innovation Capital, Allianz, and LBO France.
Biomodex operates through Biomodex Corporation.
Yes. Biomodex was acquired by Mentice in January 2023.